← Leaderboards

Stephen J Forma

City Of Hope/Beckman Research Institute

Google Scholar ↗PubMed ↗ORCID ↗

$14,356,218

Attributed

$16,632,665

Total exposure

20

Grants

16

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6.9M · FY2005–25

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$83,968,332 · 22

By mechanism

P50$39,931,830 · 11

P01$38,595,171 · 5

R01$3,282,671 · 2

U01$1,706,420 · 1

P30$277,930 · 1

U10$166,310 · 1

Top collaborators

Larry W Kwak9 shared
Tanya Siddiqi4 shared
Xiuli Wang4 shared
Anthony Stein3 shared
Jeffrey Y Wong3 shared

Others in their field

Top investigators on “Cities”

Maury Tigner · Cornell University$99,355,712
William W. Busse · University Of Wisconsin Madison$86,794,288
Kerry J Kelly · New York City Fire Department$81,924,266
Pamela B Davis · Case Western Reserve University$81,636,256
Julianne L Imperato-McGinley · Weill Medical College Of Cornell Univ$76,353,133
Bruce Neil Cronstein · New York University School Of Medicine$74,963,498

Research focus

CitiesLymphomaProgramsFundingResearch PersonnelBaseClinical ResearchAutologousInnovationRelapseTumorMalignant NeoplasmsCellsTranslational ResearchTransplantationGrantNon-Hodgkin&AposAllogenicResearch Project GrantsClinical TrialsImmunotherapyDesignCd19 GeneLaboratories

Grant awards (116)

Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma$710,483

R01 · FY2025 · CA

Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma$364,612

R01 · FY2024 · CA

Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma$705,167

R01 · FY2023 · CA

City of Hope Lymphoma SPORE$2,307,384

P50 · FY2022 · CA · contact PI

Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma$719,558

R01 · FY2022 · CA

CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma$269,863

P50 · FY2022 · CA · contact PI

Career Enhancement Program$123,114

P50 · FY2022 · CA · contact PI

Hematologic Malignancies$56,942

P30 · FY2022 · CA · contact PI

City of Hope Lymphoma SPORE$2,324,819

P50 · FY2021 · CA · contact PI

CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma$316,549

P50 · FY2021 · CA · contact PI

Career Enhancement Program$80,443

P50 · FY2021 · CA · contact PI

Hematologic Malignancies$56,942

P30 · FY2021 · CA · contact PI

City of Hope Lymphoma SPORE$2,359,066

P50 · FY2020 · CA · contact PI

CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma$264,257

P50 · FY2020 · CA · contact PI

Transfer of COVID-19 Immunity Between$176,000

P50 · FY2020 · CA · contact PI

Transfer of COVID-19 Immunity Between Allogeneic Transplant Donors and Recipients$176,000

P50 · FY2020 · CA · contact PI

Career Enhancement Program$117,509

P50 · FY2020 · CA · contact PI

Core A: Administrative Core$105,377

P50 · FY2020 · CA · contact PI

Hematologic Malignancies$64,084

P30 · FY2020 · CA · contact PI

City of Hope Lymphoma SPORE$2,324,999

P50 · FY2019 · CA · contact PI

CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma$269,479

P50 · FY2019 · CA · contact PI

Career Enhancement Program$68,651

P50 · FY2019 · CA · contact PI

Hematologic Malignancies$55,390

P30 · FY2019 · CA · contact PI

Core A: Administrative Core$47,747

P50 · FY2019 · CA · contact PI

City of Hope Lymphoma SPORE$2,500,000

P50 · FY2018 · CA · contact PI

CMV/CD19 bi-Specific CAR T cells combined with CMV vaccine as post-transplantation immunotherapy for non-Hodgkin lymphoma$281,345

P50 · FY2018 · CA · contact PI

Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$238,425

R01 · FY2018 · CA · contact PI

Career Enhancement Program$84,460

P50 · FY2018 · CA · contact PI

Core A: Administrative Core$63,967

P50 · FY2018 · CA · contact PI

Hematologic Malignancies$42,489

P30 · FY2018 · CA · contact PI

Hematologic Malignancies$2,083

P30 · FY2018 · CA · contact PI

City of Hope Lymphoma SPORE$300,000

P50 · FY2017 · CA · contact PI

Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$272,213

R01 · FY2017 · CA · contact PI

Image-guided irradiation safely intensifies HSCT regimen for refractory leukemia$272,213

R01 · FY2016 · CA · contact PI

City of Hope Lymphoma SPORE$2,185,000

P50 · FY2015 · CA · contact PI

Administrative Core$140,112

P50 · FY2015 · CA · contact PI

Career Development Program$43,303

P50 · FY2015 · CA · contact PI

Developmental Research Program$43,303

P50 · FY2015 · CA · contact PI

City of Hope Lymphoma SPORE$2,162,001

P50 · FY2014 · CA · contact PI

Administrative Core$123,367

P50 · FY2014 · CA · contact PI

Career Development Program$38,127

P50 · FY2014 · CA · contact PI

Developmental Research Program$38,127

P50 · FY2014 · CA · contact PI

City of Hope Lymphoma SPORE$2,150,500

P50 · FY2013 · CA · contact PI

Administrative Core$172,143

P50 · FY2013 · CA · contact PI

Career Development Program$53,202

P50 · FY2013 · CA · contact PI

Developmental Research Program$53,202

P50 · FY2013 · CA · contact PI

City of Hope Lymphoma SPORE$2,300,000

P50 · FY2012 · CA · contact PI

Administrative Core$146,847

P50 · FY2012 · CA · contact PI

Career Development Program$45,385

P50 · FY2012 · CA · contact PI

Developmental Research Program$45,385

P50 · FY2012 · CA · contact PI

City of Hope Lymphoma SPORE$2,185,000

P50 · FY2011 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$166,310

U10 · FY2011 · HL · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$3,041,125

P01 · FY2010 · CA · contact PI

Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and$1,148,111

P01 · FY2010 · CA · contact PI

Administration/Regulatory Affairs$469,825

P01 · FY2010 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$150,505

U01 · FY2010 · HL · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$101,770

P01 · FY2010 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$91,675

P01 · FY2010 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$88,804

P01 · FY2010 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$31,635

P01 · FY2010 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$2,987,761

P01 · FY2009 · CA · contact PI

City of Hope Lymphoma SPORE$1,079,832

P50 · FY2009 · CA · contact PI

Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and$1,070,477

P01 · FY2009 · CA · contact PI

Administration/Regulatory Affairs$436,623

P01 · FY2009 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$76,071

P01 · FY2009 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$51,365

P01 · FY2009 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$35,910

U01 · FY2009 · HL · contact PI

15th ISCT Annual Meeting$8,000

R13 · FY2009 · HL · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$2,908,648

P01 · FY2008 · CA · contact PI

City of Hope Lymphoma SPORE$2,163,322

P50 · FY2008 · CA · contact PI

Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and$1,031,002

P01 · FY2008 · CA · contact PI

Administration/Regulatory Affairs$419,933

P01 · FY2008 · CA · contact PI

Career Development Program$154,005

P50 · FY2008 · CA · contact PI

Developmental Research Program$154,005

P50 · FY2008 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$86,513

P01 · FY2008 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$1

U01 · FY2008 · HL · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$2,776,839

P01 · FY2007 · CA · contact PI

City of Hope Lymphoma SPORE$2,163,323

P50 · FY2007 · CA · contact PI

Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and$983,786

P01 · FY2007 · CA · contact PI

Administration/Regulatory Affairs$374,478

P01 · FY2007 · CA · contact PI

Developmental Research Program$148,903

P50 · FY2007 · CA · contact PI

Career Development Program$148,901

P50 · FY2007 · CA · contact PI

Hematopoietic Cell Transplantation for Hematologic Malignancies$89,324

P01 · FY2007 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$1

U01 · FY2007 · HL · contact PI

Hematopoietic Cell Transplantation for Malignancies$2,960,503

P01 · FY2006 · CA · contact PI

City of Hope Lymphoma SPORE$2,228,133

P50 · FY2006 · CA · contact PI

Radioimmunotherapy Based Transplant Regimens for Treatment of B-Cell Lymphoma and$592,132

P01 · FY2006 · CA · contact PI

Administration/Regulatory Affairs$224,270

P01 · FY2006 · CA · contact PI

Blood and Marrow Transplant Clinical Research Network$155,002

U01 · FY2006 · HL · contact PI

Developmental Research Program$80,824

P50 · FY2006 · CA · contact PI

Career Development Program$80,824

P50 · FY2006 · CA · contact PI

City of Hope Lymphoma SPORE$2,281,754

P50 · FY2005 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$359,000

P01 · FY2005 · CA

Career Development Program$78,470

P50 · FY2005 · CA

Developmental Research Program$78,470

P50 · FY2005 · CA

Blood and Marrow Transplant Clinical Research Network$1

U01 · FY2005 · HL

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$3,090,843

P01 · FY2004 · CA

City of Hope Lymphoma SPORE$2,300,000

P50 · FY2004 · CA

Blood and Marrow Transplant Clinical Research Network$405,000

U01 · FY2004 · HL

Administrative Core$152,663

P50 · FY2004 · CA

Career Development Program$76,184

P50 · FY2004 · CA

Developmental Research Program$76,184

P50 · FY2004 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$3,098,004

P01 · FY2003 · CA

Blood and Marrow Transplant Clinical Research Network$405,000

U01 · FY2003 · HL

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$100,001

P01 · FY2003 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$3,352,821

P01 · FY2002 · CA

Blood and Marrow Transplant Clinical Research Network$150,000

U01 · FY2002 · HL

AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2002 · CA

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2002 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$3,156,028

P01 · FY2001 · CA

Blood and Marrow Transplant Clinical Research Network$405,000

U01 · FY2001 · HL

AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2001 · CA

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2001 · CA

HEMATOPOIETIC CELL TRANSPLANTATION FOR MALIGNANCY$3,395,804

P01 · FY2000 · CA

AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2000 · CA

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION$0

P01 · FY2000 · CA